Skip to main content
SpringerLink
Log in

FSRT-Trial: erste Phase-III-Studie zum Vergleich fraktionierte stereotaktische Radiotherapie (FSRT) versus Einzeitradiochirurgie (SRS) bei Hirnmetastasen

FSRT-Trial: first phase III trial comparing fractionated stereotactic radiotherapy (FSRT) versus single-session radiosurgery (SRS) in brain metastases

  • Sektion B – Klinische Studien
  • Published:
Forum Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Steinmann D, Vordermark D, Gerstenberg W, Aschoff R, Gharbi N, Müller A, Schäfer C, Theodorou M, Wypior HJ, Geinitz H (2020) Quality of life in patients with limited (1–3) brain metastases undergoing stereotactic or whole brain radiotherapy : a prospective study of the DEGRO QoL working group. Strahlenther Onkol 196(1):48–57. https://doi.org/10.1007/s00066-019-01506-w

    Article  PubMed  Google Scholar 

  2. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47(2):291–298

    Article  CAS  Google Scholar 

  3. Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, Osti M, Enrici RM, Esposito V (2016) Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (〉2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95(4):1142–1148. https://doi.org/10.1016/j.ijrobp.2016.03.013

    Article  PubMed  Google Scholar 

  4. Putz F, Weissmann T, Oft D, Schmidt MA, Roesch J, Siavooshhaghighi H, Filimonova I, Schmitter C, Mengling V, Bert C, Frey B, Lettmaier S, Distel LV, Semrau S, Fietkau R (2020) FSRT vs. SRS in brain metastases-differences in local control and radiation necrosis—a volumetric study. Front Oncol 10:559193. https://doi.org/10.3389/fonc.2020.559193

    Article  PubMed  PubMed Central  Google Scholar 

  5. NCCN (2021) Central nervous system cancers (version 2.2021). https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf. Zugegriffen: 7. Okt. 2021

  6. Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M (2021) EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol. https://doi.org/10.1016/j.annonc.2021.07.016

    Article  PubMed  Google Scholar 

  7. Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R (2012) Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol 109(1):91–98. https://doi.org/10.1007/s11060-012-0868-6

    Article  PubMed  Google Scholar 

  8. Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98(3):292–297. https://doi.org/10.1016/j.radonc.2011.01.011

    Article  PubMed  Google Scholar 

  9. ICRU) ICoRUaM (2014) Report 91. Journal of the ICRU 14 (2):1–160. https://doi.org/10.1093/jicru_ndx017

  10. Schmitt D, Blanck O, Gauer T, Fix MK, Brunner TB, Fleckenstein J, Loutfi-Krauss B, Manser P, Werner R, Wilhelm ML, Baus WW, Moustakis C (2020) Technological quality requirements for stereotactic radiotherapy: expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy. Strahlenther Onkol 196(5):421–443. https://doi.org/10.1007/s00066-020-01583-2

    Article  PubMed  PubMed Central  Google Scholar 

  11. Putz F, Mengling V, Perrin R, Masitho S, Weissmann T, Rösch J, Bäuerle T, Janka R, Cavallaro A, Uder M, Amarteifio P, Doussin S, Schmidt MA, Dörfler A, Semrau S, Lettmaier S, Fietkau R, Bert C (2020) Magnetic resonance imaging for brain stereotactic radiotherapy : a review of requirements and pitfalls. Strahlenther Onkol 196(5):444–456. https://doi.org/10.1007/s00066-020-01604-0

    Article  PubMed  PubMed Central  Google Scholar 

  12. Glide-Hurst CK, Paulson ES, McGee K, Tyagi N, Hu Y, Balter J, Bayouth J (2021) Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance. Med Phys 48(7):e636–e670. https://doi.org/10.1002/mp.14695

    Article  PubMed  Google Scholar 

  13. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EGE, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270–e278. https://doi.org/10.1016/S1470-2045(15)70057-4

    Article  PubMed  Google Scholar 

  14. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104(6):907–912. https://doi.org/10.3171/jns.2006.104.6.907

    Article  PubMed  Google Scholar 

  15. Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, Reuther AM, Suh JH (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113(8):2198–2204. https://doi.org/10.1002/cncr.23821

    Article  PubMed  Google Scholar 

  16. Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23(2):170–178. https://doi.org/10.1080/02688690902755613

    Article  PubMed  Google Scholar 

  17. Narayana A, Chang J, Yenice K, Chan K, Lymberis S, Brennan C, Gutin PH (2007) Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 85(2–3):82–87. https://doi.org/10.1159/000097923

    Article  PubMed  Google Scholar 

  18. Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, Iwadate Y, Saeki N (2009) Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74(5):1543–1548. https://doi.org/10.1016/j.ijrobp.2008.10.035

    Article  PubMed  Google Scholar 

  19. Matsuyama T, Kogo K, Oya N (2013) Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer. Int J Radiat Oncol Biol Phys 85(4):984–990. https://doi.org/10.1016/j.ijrobp.2012.09.008

    Article  PubMed  Google Scholar 

  20. Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H, Lee SH (2011) Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 81(2):483–489. https://doi.org/10.1016/j.ijrobp.2010.05.033

    Article  PubMed  Google Scholar 

  21. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81(1):18–24. https://doi.org/10.1016/j.radonc.2006.08.024

    Article  PubMed  Google Scholar 

  22. Oft D, Schmidt MA, Weissmann T, Roesch J, Mengling V, Masitho S, Bert C, Lettmaier S, Frey B, Distel LV, Fietkau R, Putz F (2020) Volumetric regression in brain metastases after stereotactic radiotherapy: time course, predictors, and significance. Front Oncol 10:590980. https://doi.org/10.3389/fonc.2020.590980

    Article  PubMed  Google Scholar 

  23. Follwell MJ, Khu KJ, Cheng L, Xu W, Mikulis DJ, Millar BA, Tsao MN, Laperriere NJ, Bernstein M, Sahgal A (2012) Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response. Acta Oncol 51(5):629–635. https://doi.org/10.3109/0284186x.2012.681066

    Article  PubMed  Google Scholar 

  24. Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, Yoon YH, Lee EJ, Yang MC, Lewis RF, Harris GJ, Lev M, Schaefer PW, Buchbinder BR, Barest G, Yamada K, Ponzo J, Kwon HY, Gemmete J, Farkas J, Tievsky AL, Ziegler RB, Salhus MR, Weisskoff R (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19(2):551–557. https://doi.org/10.1200/jco.2001.19.2.551

    Article  CAS  PubMed  Google Scholar 

  25. Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Aoyama H (2017) A multi-institutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901 study update): irradiation-related complications and long-term maintenance of mini-mental state examination scores. Int J Radiat Oncol Biol Phys 99(1):31–40. https://doi.org/10.1016/j.ijrobp.2017.04.037

    Article  PubMed  Google Scholar 

  26. Soffietti R, Abacioglu U, Baumert B, Combs SE, Kinhult S, Kros JM, Marosi C, Metellus P, Radbruch A, Villa Freixa SS, Brada M, Carapella CM, Preusser M, Le Rhun E, Rudà R, Tonn JC, Weber DC, Weller M (2017) Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro-Oncology 19(2):162–174. https://doi.org/10.1093/neuonc/now241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Garsa A, Jang JK, Baxi S, Chen C, Akinniranye O, Hall O, Larkin J, Motala A, Hempel S (2021) Radiation therapy for brain metastases: a systematic review. Pract Radiat Oncol 11(5):354–365. https://doi.org/10.1016/j.prro.2021.04.002

    Article  PubMed  Google Scholar 

  28. IQWIQ (2021) Vorbericht – Stereotaktische Radiochirurgie zur Behandlung von Patientinnen und Patienten mit Hirnmetastasen (N20-04). https://www.iqwig.de/download/n20-04_stereotaktische-radiochirurgie-bei-hirnmetastasen_vorbericht_v1-0.pdf. Zugegriffen: 07.10.2021

Download references

Förderung

Die Phase-III-FSRT-Trial wird durch eine großzügige Förderung der Deutschen Krebshilfe (70113619) finanziert.

Unterstützt wird die FSRT-Trial zudem von der Arbeitsgemeinschaft Radiologische Onkologie (ARO-Studiennummer: 2021-10) und der Arbeitsgruppe Neuroradioonkologie der DEGRO (AG-NRO-05).

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054, Erlangen, Deutschland

    Florian Putz, Wiebke Pirschel &  Rainer Fietkau

Authors
  1. Florian Putz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wiebke Pirschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rainer Fietkau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Putz.

Ethics declarations

Interessenkonflikt

F. Putz, W. Pirschel und R. Fietkau geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Putz, F., Pirschel, W. & Fietkau, R. FSRT-Trial: erste Phase-III-Studie zum Vergleich fraktionierte stereotaktische Radiotherapie (FSRT) versus Einzeitradiochirurgie (SRS) bei Hirnmetastasen. Forum 37, 241–245 (2022). https://doi.org/10.1007/s12312-022-01065-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12312-022-01065-9

Search

Navigation